- Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Pulmonx Reports First Quarter 2024 Financial Results
- Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
- Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
- Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
- Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
- Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
- Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
- Pulmonx to Participate at Upcoming Investor Conferences
- Pulmonx Reports Record Third Quarter 2023 Financial Results
More ▼
Key statistics
On Friday, Pulmonx Corp (LUNG:NSQ) closed at 9.00, 26.58% above the 52 week low of 7.11 set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.09 |
---|---|
High | 9.09 |
Low | 8.89 |
Bid | 8.46 |
Offer | 10.49 |
Previous close | 9.05 |
Average volume | 361.12k |
---|---|
Shares outstanding | 38.82m |
Free float | 36.88m |
P/E (TTM) | -- |
Market cap | 349.34m USD |
EPS (TTM) | -1.54 USD |
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼